University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Survivorship data in Prostate Cancer : Where are we and where do we need to be?

dc.contributor.authorRussell, Beth
dc.contributor.authorBeyer, Katharina
dc.contributor.authorLawlor, Ailbhe
dc.contributor.authorRoobol, Monique J
dc.contributor.authorVenderbos, Lionne D.F.
dc.contributor.authorRemmers, Sebastiaan
dc.contributor.authorBriers, Erik
dc.contributor.authorMacLennan, Sara J.
dc.contributor.authorMacLennan, Steven
dc.contributor.authorOmar, Muhammad Imran
dc.contributor.authorVan Hemelrijck, Mieke
dc.contributor.authorPIONEER Consortium
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Cancer Centreen
dc.contributor.institutionUniversity of Aberdeen.Academic Urology Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2023-12-19T17:23:00Z
dc.date.available2023-12-19T17:23:00Z
dc.date.issued2024-01
dc.descriptionFunding/Support and role of the sponsor: PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The funding bodies played no direct role in this study. The views communicated here are those of PIONEER. Neither the IMI nor the European Union, EFPIA, or any associated partners are responsible for any use that may be made of the information contained herein.en
dc.description.statusPeer revieweden
dc.format.extent3
dc.format.extent278492
dc.identifier282258302
dc.identifier1a6c12b6-fd0b-4557-84cb-9592d159d527
dc.identifier38298764
dc.identifier85183640428
dc.identifier.citationRussell, B, Beyer, K, Lawlor, A, Roobol, M J, Venderbos, L D F, Remmers, S, Briers, E, MacLennan, S J, MacLennan, S, Omar, M I, Van Hemelrijck, M & PIONEER Consortium 2024, 'Survivorship data in Prostate Cancer : Where are we and where do we need to be?', European Urology Open Science, vol. 59, pp. 27-29. https://doi.org/10.1016/j.euros.2023.11.004en
dc.identifier.doi10.1016/j.euros.2023.11.004
dc.identifier.issn2666-1683
dc.identifier.otherORCID: /0000-0003-1405-6964/work/149375930
dc.identifier.otherORCID: /0000-0002-2691-8421/work/149376173
dc.identifier.otherORCID: /0000-0002-1597-3126/work/149376250
dc.identifier.urihttps://hdl.handle.net/2164/22457
dc.identifier.vol59en
dc.language.isoeng
dc.relation.ispartofEuropean Urology Open Scienceen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectCancer survivorshipen
dc.subjectprostate canceren
dc.subjectquality of lifeen
dc.subjectPROMSen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleSurvivorship data in Prostate Cancer : Where are we and where do we need to be?en
dc.typeJournal itemen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Russell_etal_EUOS_Survivorship_Data_Prostate_VOR.pdf
Size:
271.96 KB
Format:
Adobe Portable Document Format

Collections